These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 25319789

  • 1. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL, Van Nuffelen M, Lelubre C.
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M, Collins CD.
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [Abstract] [Full Text] [Related]

  • 6. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
    Hohn A, Schroeder S, Gehrt A, Bernhardt K, Bein B, Wegscheider K, Hochreiter M.
    BMC Infect Dis; 2013 Apr 01; 13():158. PubMed ID: 23547790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Procalcitonin - marker of severe infection and sepsis].
    Didebulidze K, Manjavidze N, Ubiria I, Gogberashvili K.
    Georgian Med News; 2007 Dec 01; (153):22-7. PubMed ID: 18250491
    [Abstract] [Full Text] [Related]

  • 15. Procalcitonin as a biomarker of infectious diseases.
    Lee H.
    Korean J Intern Med; 2013 May 01; 28(3):285-91. PubMed ID: 23682219
    [Abstract] [Full Text] [Related]

  • 16. [Procalcitonin: should it be measured systemically?].
    Luong Ba K, Harbarth S, Carballo S.
    Rev Med Suisse; 2013 Oct 16; 9(402):1881-2, 1884-5. PubMed ID: 24298711
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM.
    Neonatology; 2010 Oct 16; 97(2):165-74. PubMed ID: 19776651
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children.
    Pierce R, Bigham MT, Giuliano JS.
    Curr Opin Pediatr; 2014 Jun 16; 26(3):292-8. PubMed ID: 24739491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.